About Prolific Machines
Prolific Machines is a Healthcare company based in United States founded in 2020 by Declan Jones, Deniz Kent, and Max Huisman. Photomolecular biology platform is provided for controlling cellular functions dynamically. Prolific Machines has raised $105 million across 5 funding rounds from investors including Gates Foundation, SALT and Ki Tua Fund. Its chief executive, as recorded, is Deniz Kent. Prolific Machines offers products and services including Photomolecular Platform, Optogenetic Toolkit, and Illumination Systems. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Cell Culture. Its legal entity is Prolific Machines, Inc. Its competitors include BridgeBio, Spark Therapeutics and Alnylam; 3 of its 3 listed competitors have raised funding.
Company details
Prolific Machines was founded in 2020 in the United States as a biotechnology firm. A photomolecular biology platform is developed and supplied to enable precise control over cellular functions. Light, bioengineering, hardware, and AI are integrated for applications in cultivated meat production, nutritional and therapeutic proteins, pharmaceuticals, and various bioproducts. Operations focus on advancing dynamic cellular manipulation within the biotech sector.
- Headquarters United States
- Founders Declan Jones, Deniz Kent, Max Huisman
- SectorsHealthcare
- Email••••••••
- Website prolific-machines.com
- Social LinkedIn X
- Legal Name Prolific Machines, Inc.
- Total Equity Funding$105M (USD)
in 5 rounds
- Latest Funding Round$50M (USD), Series B
Oct 2026
- InvestorsGates Foundation
& 33 more
Products & Services of Prolific Machines
Prolific Machines offers a comprehensive portfolio of products and services, including Photomolecular Platform, Optogenetic Toolkit, and Illumination Systems.
Platform for precise light-based control of cellular functions in protein production.
Genetic constructs to control major cellular functions using light signals.
Systems for efficient light control in biomanufacturing processes.
Funding Insights of Prolific Machines
Prolific Machines has successfully raised a total of $105M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $50 million completed in October 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $105M
- Total Rounds 5
- Last Round Series B — $50M
- Investors Count 34
All 5 funding rounds of Prolific Machines with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2026 | $50M | Series B | – | – | |
| Aug 2024 | Grant | – | – | ||
| May 2024 | $55M | Series B | – | Ki Tua Fund | |
| Sep 2022 | Series A | – | Breakthrough Energy | ||
| Jun 2020 | Seed | – | IndieBio | – |
34 investors in total: 16 institutional and 18 angel.
Investors in Prolific Machines
Prolific Machines has secured backing from 34 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Gates Foundation, SALT and Ki Tua Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Ki Tua Fund is focused on investing in health-focused startups. | kituafund.com | |||
Climate solutions are advanced via venture capital and startup acceleration. | breakthroughenergy.org | Kirkland, United States | ||
Mayfield is focused on AI innovation and venture capital investments. | mayfield.com | Menlo Park, United States | ||
Venture capital and accelerator services are provided across multiple sectors. | sosv.com | Cork, Ireland | ||
Investment is made in cutting-edge technology by Shorewind Capital. | shorewindcapital.com | |||
Darco Capital is engaged in investing in diverse sectors. | darcocapital.com | Philadelphia, United States | ||
Venture capital firm | iqt.org | Washington, Dc, United States | ||
Investments are directed to food, agribusiness, and commodities sectors. | continentalgrain.com | New York, United States | ||
Investments and family assets are managed by The Kraft Group. | thekraftgroup.com | Foxborough, United States | ||
Venture capital firm | breyercapital.com | Menlo Park, United States |
Investor details for Prolific Machines
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Prolific Machines
23 people are tracked at Prolific Machines (13 in leadership, 10 in team).
| Name | Role | Group |
|---|---|---|
Declan Jones | Co-Founder & CIO | Leadership |
Deniz Kent | Co-Founder & CEO | Leadership |
Max Huisman | Co-Founder & CTO | Leadership |
Christina Perry | Chief Financial Officer | Leadership |
Kiana Mohajeri-Stickels, PhD | Head Of Synthetic Biology | Leadership |
Ian Ronningen | Head Of Product Innovation And Analytical Chemistry | Leadership |
Lily Paloma | Head Of People | Leadership |
George Hosegood | Head Of Operations | Leadership |
Vidar van der Meijden | Vice President Of Product | Leadership |
Ianessa Morantte | Head Of Therapeutics Research And Development | Leadership |
Alex Toda | Senior Director Of Technical Operations | Leadership |
John R Haliburton | Head Of Cell Line Development | Leadership |
Madeleine Allen | Head Of Prototyping | Leadership |
Victor Jones | CSO | Team |
Rafael Daigle | Facilities Operations Manager | Team |
Will Paton | Staff Bioprocess Engineer | Team |
Basanta Dahal | Senior Scientist | Team |
Baxter Eldridge | Senior Mechatronics Engineer | Team |
Mary A. | Research Associate II | Team |
Brandon Nguyen | Bioprocess Engineering Research Associate | Team |
3 more people are available in the full profile.
Complete people profiles for Prolific Machines
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Prolific Machines
3 dated milestones of Prolific Machines across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Prolific Machines is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $50.0M.
Competitors of Prolific Machines
Prolific Machines has 3 listed competitors in our database, 3 of them funded. They include BridgeBio, Spark Therapeutics and Alnylam.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bridgebio.com | 2015 | Palo Alto, United States | $434.2M | Therapeutics for genetic diseases are developed through targeted interventions. | ||
| sparktx.com | 2013 | Philadelphia, United States | $82.8M | 822 | Gene therapies for rare diseases including retinal dystrophies are developed. | |
| alnylam.com | 2002 | Cambridge, United States | $17M | 2,100 | RNA interference-based therapeutics are developed for multiple disorders. |
Detailed competitors of Prolific Machines
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Prolific Machines
The website of Prolific Machines (prolific-machines.com) receives about 3.1K visits a month.
- Monthly visits3.1K
▲ 34.4% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Prolific Machines (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Prolific Machines
Complete news archive for Prolific Machines
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prolific Machines
Prolific Machines was founded in 2020.
Prolific Machines is headquartered in United States.
Deniz Kent is the CEO of Prolific Machines, as recorded in our data. They have also founded this company.
Prolific Machines is a funded company, having raised a total of $105M across 5 funding rounds to date.
Prolific Machines was founded in 2020 in the United States as a biotechnology firm. A photomolecular biology platform is developed and supplied to enable precise control over cellular functions. Light, bioengineering, hardware, and AI are integrated for applications in cultivated meat production, nutritional and therapeutic proteins, pharmaceuticals, and various bioproducts. Operations focus on advancing dynamic cellular manipulation within the biotech sector.
Prolific Machines's top competitors include Spark Therapeutics, BridgeBio and Alnylam.
Prolific Machines offers Photomolecular Platform, Optogenetic Toolkit, and Illumination Systems.
Prolific Machines has 34 investors. Key investors include Gates Foundation, SALT, Ki Tua Fund, Breakthrough Energy, and Mayfield.
Prolific Machines operates through Prolific Machines, Inc..